Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

A mature man with glasses and a bald head, dressed in a white lab coat, light blue shirt, and light green tie, stands in front of a blurred background with indistinct text—identified as Lluís Puig.

Lluís

Puig

,

MD, PhD

Department of Dermatology Director
Hospital de la Santa Creu i Sant Pau
Barcelona
,
Spain
Councilor Since: March 1, 2012
IPC Board Member
Dr. Lluís Puig is Director of the Department of Dermatology at the Hospital de la Santa Creu i Sant Pau (HSCSP) and a Professor of Dermatology at the Universitat Autònoma de Barcelona (UAB) Medical School, Barcelona, Spain.

In the last 20 years, Dr. Puig has focused on clinical research in the treatment of psoriasis with biological agents, an area in which he is considered a key opinion leader both nationally and internationally, having taught at numerous national and international conferences, workshops, and seminars. The results of his research have been published in numerous articles and textbooks. He has participated in numerous clinical trials on psoriasis, in most cases acting as principal investigator.

Dr. Puig is a member of the Spanish Academy of Dermatology and Venereology, a founding member of several of its working groups, and past coordinator of the Spanish Psoriasis Group. He is also an aggregate member of the Spanish Society of Rheumatology and its GEAPSO Group for Research in Psoriatic Arthritis, and of several international societies, including the EADV, AAD, CILAD, ESDR, ASDP, ISDP, and GRAPPA.

He has held numerous senior leadership and advisory roles within leading international dermatology and psoriasis organizations, including serving as a Board Member of the European Academy of Dermatology and Venereology (EADV) from 2013 to 2019 and currently as Co-Chair of its Psoriasis Task Force (since 2018). He is both Scientific Advisor and President of the Psoriasis International Network. Dr. Puig has served on the Scientific Board Executive Committee and as Vice President of the Administrative Council of the Fondation René Touraine (2016–2020 and 2018–2020, respectively). He is a Member of the European Dermatology Forum (since 2017), and has been actively involved with the International Psoriasis Council (IPC) as a Councilor since 2012, becoming a Board Member in 2018. In addition, he has contributed to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) as a member of the Education and Steering Committees (2020–2023), and he currently serves as a Board Member-at-Large (Dermatology) since 2024.
Last Updated:
03/03/2026

Areas of Interest

Clinical Research, Comorbidities, Genetics

IPC Committees / Groups

Board Member, Editorial Committee, Emerging Infectious Diseases Task Force, Governance Committee

Languages Spoken

Catalan, English, French, Spanish

Involvement with Other Organization(s)

Dr. Puig is an occasional consultant and lectures to the national patient association; he has also served as a regional-level consultant to the health ministry.

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026